Search results for " vivo"

showing 10 items of 1661 documents

Osseoconductivity of a Specific Streptavidin-Biotin-Fibronectin Surface Coating of Biotinylated Titanium Implants - A Rabbit Animal Study

2015

Background Biofunctionalized implant surfaces may accelerate bony integration and increase long-term stability. Purpose The aim of the study was to evaluate the osseous reaction toward biomimetic titanium implants surfaces coated with quasicovalent immobilized fibronectin in an in vivo animal model. Materials and Methods A total of 84 implants (uncoated [control 1, n = 36], streptavidin–biotin coated [test 1, n = 24], streptavidin–biotin–fibronectin coated [test 2, n = 24]) were inserted 1 mm supracortically in the proximal tibia of 12 rabbits. The samples were examined after 3 and 6 weeks. Total bone-implant contact (tBIC; %), bone-implant contact in the cortical (cBIC; %) and in the spong…

Bone growthmedicine.medical_specialtybiologyChemistrychemistry.chemical_elementOsseointegrationSurgeryFibronectinSurface coatingIn vivoBiotinylationmedicinebiology.proteinImplantOral SurgeryGeneral DentistryBiomedical engineeringTitaniumClinical Implant Dentistry and Related Research
researchProduct

Aza-BODIPY: A New Vector for Enhanced Theranostic Boron Neutron Capture Therapy Applications

2020

Boron neutron capture therapy (BNCT) is a radiotherapeutic modality based on the nuclear capture of slow neutrons by stable 10B atoms followed by charged particle emission that inducing extensive damage on a very localized level (&lt

Boron CompoundsBiodistributionboron compound[SDV.BIO]Life Sciences [q-bio]/BiotechnologyFluorophorein ovo modelAstrophysics::High Energy Astrophysical Phenomena[SDV]Life Sciences [q-bio]theranosticNuclear TheoryPhysics::Medical Physicsaza-BODIPY[SDV.CAN]Life Sciences [q-bio]/CancerBoron Neutron Capture Therapy010402 general chemistry01 natural sciencesSodium BorocaptateArticle03 medical and health scienceschemistry.chemical_compoundoptical imagingNIR-IMice0302 clinical medicine[SDV.CAN] Life Sciences [q-bio]/CancerPhysics::Atomic and Molecular ClustersAnimalsHumansNeutronNuclear Experiment10 B-BSHlcsh:QH301-705.5<sup>10</sup>B-BSHChemistryRadiochemistry10B-BSHGeneral MedicineFluorescence[SDV.BIO] Life Sciences [q-bio]/Biotechnology0104 chemical sciencesSWIR[SDV] Life Sciences [q-bio]Neutron capturelcsh:Biology (General)030220 oncology & carcinogenesisBNCTFemaleBODIPYEx vivoCells
researchProduct

A Promising Family of Fluorescent Water-Soluble aza-BODIPY Dyes for in Vivo Molecular Imaging.

2019

A new family of water-soluble and bioconjugatable aza-BODIPY fluorophores was designed and synthesized using a boron- functionalization strategy. These dissymmetric bis-ammonium aza-BODIPY dyes present optimal properties for a fluorescent probe; i.e., they are highly water-soluble, very stable in physiological medium; they do not aggregate in PBS, possess high quantum yield; and finally, they can be easily bioconjugated to antibodies. Preliminary in vitro and in vivo studies were performed for one of these fluorophores to image PD-L1 (Programmed Death-Ligand 1), highlighting the high potential of these new probes for future in vivo optical imaging studies.

Boron CompoundsBiomedical EngineeringPharmaceutical ScienceQuantum yieldBioengineering02 engineering and technology01 natural sciencesMiceIn vivoCell Line TumorAza-bodipyAnimalsHumansFluorescent DyesPharmacologyMice Inbred BALB C010405 organic chemistryChemistryOrganic ChemistryWater021001 nanoscience & nanotechnologyCombinatorial chemistryFluorescenceIn vitro0104 chemical sciences3. Good healthMolecular ImagingWater solubleSolubilitySurface modificationHeterograftsMolecular imaging0210 nano-technologyBiotechnologyBioconjugate chemistry
researchProduct

Development of an Easily Bioconjugatable Water-Soluble Single-Photon Emission-Computed Tomography/Optical Imaging Bimodal Imaging Probe Based on the …

2021

A water-soluble fluorescent aza-BODIPY platform (Wazaby) was prepared and functionalized by a polyazamacrocycle agent and a bioconjugable arm. The resulting fluorescent derivative was characterized and bioconjugated onto a trastuzumab monoclonal antibody as a vector. After bioconjugation, the imaging agent appeared to be stable in serum (>72 h at 37 °C) and specifically labeled HER-2-positive breast tumors slices. The bioconjugate was radiolabeled with [111In] indium and studied in vivo. The developed monomolecular multimodal imaging probe (MOMIP) is water-soluble and chemically and photochemically stable, emits in the near infrared (NIR) region (734 nm in aqueous media), and displays a goo…

Boron CompoundsFluorescence-lifetime imaging microscopyFluorophoreMice NudeQuantum yieldBreast Neoplasms01 natural sciencesMiceStructure-Activity Relationship03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNuclear magnetic resonanceDrug DevelopmentIn vivoDrug DiscoveryAnimalsHumansFluorescent DyesTomography Emission-Computed Single-PhotonBioconjugationDose-Response Relationship DrugMolecular Structure010405 organic chemistryOptical ImagingNear-infrared spectroscopyAntibodies MonoclonalMammary Neoplasms ExperimentalWaterHep G2 CellsFluorescenceImaging agent0104 chemical sciences3. Good healthSolubilitychemistry030220 oncology & carcinogenesisMolecular MedicineFemaleJournal of Medicinal Chemistry
researchProduct

Near-infrared emitting fluorescent homobimetallic gold(I) complexes displaying promising in vitro and in vivo therapeutic properties

2021

International audience; Boron neutron capture therapy (BNCT) has the potential to specifically destroy tumor cells without damaging the tissues infiltrated by the tumor. BNCT is a binary treatment method based on the combination of two agents that have no effect when applied individually: 10B and thermal neutrons. Exclusively, the combination of both produces an effect, whose extent depends on the amount of 10B in the tumor but also on the organs at risk. It is not yet possible to determine the 10B concentration in a specific tissue using non-invasive methods. At present, it is only possible to measure the 10B concentration in blood and to estimate the boron concentration in tissues based o…

Boron Compoundsinorganic chemicalsCell SurvivalInfrared RaysAntineoplastic Agents01 natural sciencesMiceStructure-Activity Relationship03 medical and health sciencesOptical imagingCoordination ComplexesIn vivoDrug DiscoveryTumor Cells CulturedAza-bodipyAnimalsHumans[CHIM]Chemical SciencesNir fluorescenceComputingMilieux_MISCELLANEOUSCell ProliferationFluorescent Dyes030304 developmental biologyPharmacologyAza CompoundsMice Inbred BALB C0303 health sciencesDose-Response Relationship DrugMolecular Structure010405 organic chemistryChemistryOptical ImagingOrganic ChemistryNear-infrared spectroscopyNeoplasms ExperimentalGeneral MedicineFluorescenceIn vitro3. Good health0104 chemical sciencesBiophysicsGoldDrug Screening Assays AntitumorCancer cell lines
researchProduct

Immunohistochemical Detection of Binding of Cryia Crystal Proteins of Bacillus thuringiensis in Highly Resistant Strains of Plutella xylostella (L.) …

1995

We detected binding of insecticidal crystal proteins from Bacillus thuringiensis in one susceptible strain and six resistant strains of diamondback moth, Plutella xylostella, from Hawaii. Immunohistochemical tests with tissue sections from larval midguts showed specific binding of CryIA(a), CryIA(b), and CryIA(c) to brush border membranes. CryIE, which is not toxic to P. xylostella, did not bind to midgut tissues. Larvae from one of the resistant strains ingested extremely high concentrations of a commercial formulation containing the three CryIA proteins without suffering midgut cell damage or mortality. This same resistant strain had previously been found to have greatly reduced binding o…

Brush borderBacterial ToxinsBacillus thuringiensisBiophysicsMothsHemolysin ProteinsBiochemistryEpitheliumHawaiiInsecticide ResistanceHemolysin ProteinsBacterial ProteinsIn vivoBacillus thuringiensisBotanyAnimalsPest Control BiologicalMolecular BiologyDiamondback mothBacillus thuringiensis ToxinsMicrovillibiologyStrain (chemistry)fungiPlutellaMidgutCell Biologybiology.organism_classificationImmunohistochemistryMolecular biologyEndotoxinsLarvaBiochemical and Biophysical Research Communications
researchProduct

Multiple in vitro and in vivo regulatory effects of budesonide in CD4+ T lymphocyte subpopulations of allergic asthmatics.

2012

Abstract BACKGROUND: Increased activation and increased survival of T lymphocytes characterise bronchial asthma. OBJECTIVES: In this study the effect of budesonide on T cell survival, on inducible co-stimulator T cells (ICOS), on Foxp3 and on IL-10 molecules in T lymphocyte sub-populations was assessed. METHODS: Cell survival (by annexin V binding) and ICOS in total lymphocytes, in CD4+/CD25+ and in CD4+/CD25- and Foxp3 and IL-10 in CD4+/CD25+ and in CD4+/CD25-cells was evaluated, by cytofluorimetric analysis, in mild intermittent asthmatics (n = 19) and in controls (n = 15). Allergen induced T lymphocyte proliferation and the in vivo effects of budesonide in mild persistent asthmatics (n =…

BudesonideCD4-Positive T-LymphocytesMalePulmonologylcsh:Medicineimmune system diseasesT-Lymphocyte SubsetsMolecular Cell Biologylcsh:ScienceBudesonidecigarette smoke airway epithelial cells reactive oxygen species.MultidisciplinaryT CellsAllergy and HypersensitivityClinical Pharmacologyhemic and immune systemsForkhead Transcription Factorsrespiratory systemMiddle AgedFlow CytometryBronchodilator AgentsInterleukin-10Interleukin 10MedicineFemalemedicine.drugResearch ArticleAdultDrugs and DevicesAdolescentCell SurvivalImmune CellsImmunologychemical and pharmacologic phenomenaInducible T-Cell Co-Stimulator ProteinImmunomodulationIn vivomedicineHumansInducible T-Cell Co-Stimulator ProteinBiologyAsthmaCell Proliferationbusiness.industrylcsh:RT lymphocytemedicine.diseaseIn vitroAsthmarespiratory tract diseasesApoptosisImmunologylcsh:QClinical ImmunologybusinessCytometryPloS one
researchProduct

C1q induces in vivo angiogenesis and promotes wound healing

2011

C1q; angiogenesisangiogenesisChemistryAngiogenesisIn vivoImmunologyCancer researchSettore MED/08 - Anatomia PatologicaWound healingMolecular BiologyC1q
researchProduct

C57BL/6-specific conditions for efficient in utero electroporation of the central nervous system.

2014

Abstract Background In utero electroporation is a fast an efficient tool to specifically address gene expression in the murine central nervous system. This technique was originally established in ICR/CD-1 outbred mice. Neuroanatomical differences between the different mouse strains and variations in gestation length require the optimization of the conditions for each strain to avoid severe complications. Furthermore the relevant position information is currently only scarcely standardized and not always easy to transfer to C57BL/6 mice. New method In this study we present an improved method for in utero electroporation of C57BL/6 including a detailed atlas that allows for specific and effic…

C57BL/6Central Nervous SystemPathologymedicine.medical_specialtyCentral nervous systemGreen Fluorescent ProteinsImproved methodTransfectionAtlases as TopicSpecies SpecificityCell MovementIn vivo transfectionmedicineAnimalsNeuronsMicroscopy ConfocalbiologyGeneral NeuroscienceElectroporationTransfectionbiology.organism_classificationCell biologyMice Inbred C57BLmedicine.anatomical_structureElectroporationIn uteroGestation lengthJournal of neuroscience methods
researchProduct

Inhibition of T cell activityin vivo: a test model for quantitative evaluation

1976

A test model is presented which, in comparison with the conventional models of skin transplantation or graft-versus-host (GvH) reaction in mice, permits a more sensitive quantitative evaluation of T cell inhibition in vivo. Prospective donors (type AA) are immunized with prospective recipient material (type AB); the resulting T cell reaction of A versus B is inhibited by consecutive treatment. Extent of inhibition can be evaluated after transfer of the pretreated AA material onto AB recipients by calculation of remaining GvH reactivity, if compared to adequate control tranfers. In this model the target animal for T cell reactivity (the AB recipient) remains untouched from immunosuppressive …

C57BL/6T-LymphocytesT cellImmunologyGraft vs Host ReactionMice Inbred StrainsSpleenThymus GlandBiologyPharmacologyModels BiologicalGraft vs Host ReactionMiceIn vivoMethodsmedicineAnimalsImmunology and AllergyBioassayReactivity (chemistry)biology.organism_classificationSkin transplantationmedicine.anatomical_structureLiverImmunologySpleenEuropean Journal of Immunology
researchProduct